SCHEMBL6510478

SCHEMBL6510478

CN(c1ccc2sc(C(=O)NO)cc2c1)S(=O)(=O)c1ccc(Cl)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.44
SIRT2 Q8IXJ6 4/20 0.43
HDAC1 Q13547 4/20 0.43
HDAC3 O15379 2/20 0.43
HDAC4 P56524 2/20 0.43
HDAC7 Q8WUI4 2/20 0.43
HDAC2 Q92769 2/20 0.43
HDAC10 Q969S8 2/20 0.43
HDAC11 Q96DB2 2/20 0.43
HDAC8 Q9BY41 2/20 0.43
HDAC6 Q9UBN7 2/20 0.43
HDAC9 Q9UKV0 2/20 0.43
HDAC5 Q9UQL6 2/20 0.43
GPR27 Q9NS67 1/20 0.42
PGR P06401 1/20 0.42
FLT1 P17948 1/20 0.42
FLT4 P35916 1/20 0.42
KDR P35968 1/20 0.42
HTT P42858 2/20 0.41
KDM4E B2RXH2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6507296 0.88 HDAC1 (0.52) ALDH1A1HDAC1HDAC3HDAC4HDAC7
SCHEMBL6509900 0.87 HTT (0.49) ALDH1A1HDAC1HDAC3HDAC4HDAC7
SCHEMBL6510386 0.83 HDAC1 (0.47) ALDH1A1HDAC1HDAC3HDAC4HDAC7
SCHEMBL6510460 0.76 PTPN22 (0.50) ALDH1A1SIRT2HDAC1HDAC3HDAC4
SCHEMBL6508074 0.75 HDAC1 (0.63) HDAC1HDAC3HDAC4HDAC7HDAC2
SCHEMBL6510476 0.73 HDAC1 (0.55) ALDH1A1HDAC1HDAC3HDAC4HDAC7
SCHEMBL16396008 0.71 MEN1 (0.44) ALDH1A1HDAC1HTTKDM4EMAPK1
SCHEMBL16396217 0.71 CLK1 (0.45) ALDH1A1HTTKDM4EMAPK1L3MBTL1
SCHEMBL11764723 0.71 PGR (0.71) ALDH1A1PGRHTTKDM4EMAPK1
SCHEMBL1884928 0.69 HDAC1 (0.79) ALDH1A1HDAC1HDAC3HDAC4HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005066151-A2 HISTONE DEACETYLASE INHIBITORS TAKEDA SAN DIEGO, INC. (US) 2005-07-21 WO claimed
US-20050137234-A1 Histone deacetylase inhibitors SYRRX, INC. 2005-06-23 US claimed
WO-2005066151-A2 HISTONE DEACETYLASE INHIBITORS TAKEDA SAN DIEGO, INC. (US) 2005-07-21 WO disclosed
US-20050137234-A1 Histone deacetylase inhibitors SYRRX, INC. 2005-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050137234-A1 Histone deacetylase inhibitors HDAC1, HDAC5, HDAC11 ALDH1A1 1731/4885SIRT2 43/4885HDAC1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.